Seikagaku Corp 4548.T-JP:Tokyo Stock Exchange

*Data is delayed | Exchange | JPY
Last | 9:31 AM JST
742.00quote price arrow down-4.00 (-0.54%)
Volume
27,700
52 week range
726.00 - 857.00
Loading...
  • Open744.00
  • Day High745.00
  • Day Low742.00
  • Prev Close746.00
  • 52 Week High857.00
  • 52 Week High Date05/09/23
  • 52 Week Low726.00
  • 52 Week Low Date12/18/23

Key Stats

  • Market Cap261.22M
  • Shares Out54.56M
  • 10 Day Average Volume73,422.22
  • Dividend26.00
  • Dividend Yield3.50%
  • Beta-
  • YTD % Change-2.5

KEY STATS

  • Open744.00
  • Day High745.00
  • Day Low742.00
  • Prev Close746.00
  • 52 Week High857.00
  • 52 Week High Date05/09/23
  • 52 Week Low726.00
  • 52 Week Low Date12/18/23
  • Market Cap261.22M
  • Shares Out54.56M
  • 10 Day Average Volume73,422.22
  • Dividend26.00
  • Dividend Yield3.50%
  • Beta-
  • YTD % Change-2.5

RATIOS/PROFITABILITY

  • EPS (TTM)47.70
  • P/E (TTM)15.56
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date09/28/2023
  • Div Amount13.00
  • Split Date-
  • Split Factor-

Latest On Seikagaku Corp

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
SEIKAGAKU CORPORATION is principally engaged in the research, development, purchase, manufacture and sale of pharmaceutical products and limulus amebocyte lysate (LAL). The Company operates in two business segments. The Pharmaceutical business segment provides hyaluronan-based medicines for joint function improvement, ophthalmic operation boosters and submucosal injection materials for endoscopes, as well as drug substances for various pharmaceuticals. The LAL business...
Ken Mizutani
President, Chief Executive Officer, Representative Director
Address
10F, Marunouchi Center Bldg
1-6-1, Marunouchi
Chiyoda-ku, TKY
100-0005
Japan